Quantum

QCi Reports $9.5 Million in Quarterly Revenue as Acquisitions Expand Commercial Business

Read full article at source ↗

Based on a feed excerpt; full article content has not been acquired. Source evidence retrieved 10/11/2026, 09:49:24 UTC.

Briefings

Quantum Computing Inc. reported $9.5 million in third-quarter revenue, driven by acquisitions that contributed 93% of sales. The company ended with $1.3 billion in cash and a $39.1 million contract backlog. While revenue excluding acquisitions rose slightly, the full-year comparison showed a 37% decline due to prior-year acquisitions. CEO Dr. Yuping Huang emphasized shifting focus from building technology to applying it commercially.

Key points

• Acquisitions from Luminar Semiconductor, NuCrypt, and NHanced Semiconductors generated 93% of the $9.5 million quarterly revenue.
• The company signed its first pharmaceutical customer, INmune Bio, for quantum optimization technology applied to Alzheimer's research.

Context

Quantum Computing Inc. expanded its photonics and semiconductor manufacturing business through strategic acquisitions, significantly altering its revenue structure and operational capabilities.

Limitations

Revenue excluding acquisitions increased only slightly, while full-year comparisons show a 37% decline due to prior-year acquisitions. Specific financial values for the INmune Bio agreement remain undisclosed.

Generated by Bittrees-hosted qwen35-2b sha256:aaf42c8b7c3c on 10/11/2026, 10:13:03 UTC. Based on publisher-provided feed evidence; may not cover the full original article. Check the source for details.

View archived briefing on IPFS
bafybeidxgygxuc2eb36t3cpzcymifmfjvrzfa7atnarbtvbco7wkfe57la